Literature DB >> 17167528

An internationally recognized uniform cytogenetic classification system is needed for multiple myeloma.

A Dispenzieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17167528     DOI： 10.1038/sj.leu.2404450

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie.

Authors:  Prashant Kapoor; Rafael Fonseca; S Vincent Rajkumar; Shirshendu Sinha; Morie A Gertz; A Keith Stewart; P Leif Bergsagel; Martha Q Lacy; David D Dingli; Rhett P Ketterling; Francis Buadi; Robert A Kyle; Thomas E Witzig; Philip R Greipp; Angela Dispenzieri; Shaji Kumar
Journal:  Mayo Clin Proc       Date:  2010-06       Impact factor: 7.616

2.  Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone.

Authors:  Prashant Kapoor; Shaji Kumar; Rafael Fonseca; Martha Q Lacy; Thomas E Witzig; Suzanne R Hayman; Angela Dispenzieri; Francis Buadi; P Leif Bergsagel; Morie A Gertz; Robert J Dalton; Joseph R Mikhael; David Dingli; Craig B Reeder; John A Lust; Stephen J Russell; Vivek Roy; Steven R Zeldenrust; A Keith Stewart; Robert A Kyle; Philip R Greipp; S Vincent Rajkumar
Journal:  Blood       Date:  2009-03-26       Impact factor: 22.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.